gtx-024
Showing 1 - 8 of 8
ER+ and AR+ Breast Cancer Trial in United States (GTx-024)
Completed
- ER+ and AR+ Breast Cancer
- GTx-024
-
Fort Lauderdale, Florida
- +3 more
Dec 8, 2020
Triple Negative Breast Cancer Trial in United States (GTx-024)
Terminated
- Triple Negative Breast Cancer
- GTx-024
-
Fort Lauderdale, Florida
- +6 more
Oct 29, 2020
Muscle Wasting, NSCLC Trial in United States (GTx-024, )
Completed
- Muscle Wasting
- Non-Small Cell Lung Cancer
- GTx-024
- placebo
-
Birmingham, Alabama
- +29 more
Oct 26, 2020
Stress Urinary Incontinence Trial in United States (GTx-024)
Terminated
- Stress Urinary Incontinence
- GTx-024
-
Homewood, Alabama
- +45 more
Sep 27, 2018
Stress Urinary Incontinence Trial in United States (GTx-024, Matching Placebo)
Terminated
- Stress Urinary Incontinence
- GTx-024
- Matching Placebo
-
Homewood, Alabama
- +45 more
Sep 27, 2018
Muscle Wasting, Non Small Cell Lung Cancer Trial in United States (GTx-024, )
Completed
- Muscle Wasting
- Non Small Cell Lung Cancer
- GTx-024
- placebo
-
Birmingham, Alabama
- +26 more
Feb 4, 2016